Azienda Ospedaliera Universitaria Federico II — Naples

Public research footprint of Azienda Ospedaliera Universitaria Federico II, compiled from the ClinicalTrials.gov public registry.

243

Registered studies

104

Active

Recruiting now

102

Completed

Stopped or withdrawn

Most-studied conditions

Immune Thrombocytopenic Purpura (ITP) · Clostridium Difficile Infection Recurrence · Clostridioides Difficile Infection Recurrence · Urinary Bladder Neoplasms

Recently updated registry entries

NCT06880744 — A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to… (Active Not Recruiting)
NCT06012240 — A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and… (Recruiting)
NCT07071519 — A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Azienda Ospedaliera Universitaria Federico II?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.